bPiDI

1 Cited Publications
Revisión del cliente

Based on 1 publication(s) in Google Scholar

bPiDI is a novel selective α6β2 nicotinic receptor antagonist. bPiDI inhibits nicotine-evoked striatal dopamine (DA) release through an interaction with α6β2-containing nAChRs.

Para uso exclusivo en investigación. No vendemos a pacientes.

  • Pureza: 99.65%
  • No. CAS: 525596-64-9
  • Fòrmula: C22H34I2N2
  • Peso molecular:580.33
  • Almacenamiento:

    4°C, sealed storage, away from moisture

    * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)

  • Actividad biológica
  • Chemical Information
  • Solvente y solubilidad
  • Pureza y Documentación
  • Referencias
  • Help & FAQs

Publications Citing Use of MedChemExpress (MCE) bPiDI

More
MOQ
Minimum order quantity
100 mg

Obtener un presupuesto En stock

Other size
Obtener un presupuesto
Please select quantity
Amount: USD 0.00